Brett Hagen
Comptroller/Controller/Auditor chez ALLOVIR, INC.
Fortune : 58 602 $ au 31/03/2024
Profil
Mr. Brett R.
Hagen is a Chief Accounting Officer at AlloVir, Inc. Mr. Hagen was previously employed as a Senior Director-Finance & Accounting by Eloxx Pharmaceuticals, Inc., a Chief Accounting Officer & Vice President-Finance by Proteostasis Therapeutics, Inc., a Controller by BIND Therapeutics, Inc., a Vice President-Finance by Boston Private Financial Holdings, Inc., and a Controller by BioProcessors Corp.
He received his undergraduate degree from the University of Minnesota, a graduate degree from Wright State University (Ohio) and a graduate degree from Suffolk University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLOVIR INC
0,07% | 22/04/2024 | 77 619 ( 0,07% ) | 58 602 $ | 31/03/2024 |
Postes actifs de Brett Hagen
| Sociétés | Poste | Début |
|---|---|---|
| ALLOVIR, INC. | Comptroller/Controller/Auditor | 01/01/2019 |
Anciens postes connus de Brett Hagen
| Sociétés | Poste | Fin |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/08/2018 |
| PROTEOSTASIS THERAPEUTICS, INC. | Director of Finance/CFO | 25/07/2017 |
| DNIB UNWIND INC | Comptroller/Controller/Auditor | 01/05/2016 |
| BOSTON PRIVATE FINANCIAL HOLDINGS, INC. | Director of Finance/CFO | 01/07/2014 |
BioProcessors Corp.
 BioProcessors Corp. Electronic Equipment/InstrumentsElectronic Technology BioProcessors, Inc. provides micro-engineered solutions for the biotechnology and pharmaceutical industry. It offers biomanufacturing workflow methods and technologies that help scientists to optimize the process development. The company was founded by Andrey Zarur in October 2000 and is located in Woburn, MA. | Comptroller/Controller/Auditor | - |
Formation de Brett Hagen
| Suffolk University | Graduate Degree |
| University of Minnesota | Undergraduate Degree |
| Wright State University (Ohio) | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Boston Private Financial Holdings, Inc.
 Boston Private Financial Holdings, Inc. Regional BanksFinance Boston Private Financial Holdings, Inc. engages in the provision of banking services. It operates through the Private Banking; and Wealth Management and Trust segments. The Private Banking segment offers services to privately owned businesses, private partnerships, and non-profit organizations. The Wealth Management and Trust segment offers planning-based financial strategies, wealth management, family office, financial planning, tax planning, and trust services to individuals, families, institutions, and nonprofit institutions. The company was founded on September 2, 1987 and is headquartered in Boston, MA. | Finance |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
BioProcessors Corp.
BioProcessors Corp. Electronic Equipment/InstrumentsElectronic Technology BioProcessors, Inc. provides micro-engineered solutions for the biotechnology and pharmaceutical industry. It offers biomanufacturing workflow methods and technologies that help scientists to optimize the process development. The company was founded by Andrey Zarur in October 2000 and is located in Woburn, MA. | Electronic Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
